17 Stocks That May Have A Monster Final 4 Months of 2018
It’s September, and the chase for performance is on as investors flock into some of the hottest stocks around. We give you 17 that may have a monster final four months.
Read moreDaily Market Analysis By Michael Kramer
It’s September, and the chase for performance is on as investors flock into some of the hottest stocks around. We give you 17 that may have a monster final four months.
Read more[widget id=”text-22″] [widget id=”text-28″] 6 More Monster Predictions for Earnings The Week of July 23 MICHAEL KRAMER AND THE CLIENTS OF MOTT CAPITAL OWN SHARES OF NXPI [widget id=”text-19″] There…
Read more[widget id=”text-22″] [widget id=”text-23″] The Stock Market Is A Battle of Good and Bad As Uncertainty Runs Wild [widget id=”text-19″] MICHAEL KRAMER OWNS XLF PUTS Michael Kramer and the clients…
Read more[widget id=”text-24″] [widget id=”text-22″] Facebook, Alphabet, Tesla, Intel, Biogen, Gilead, Oil – The Daily Rundown June 18 MICHAEL KRAMER AND THE CLIENTS OF MOTT CAPITAL OWN SHARES OF TSLA AND…
Read moreBiotech Stocks May Have Finally Been Unleashed Michael Kramer and the Clients of Mott Capital Own CELG [widget id=”text-19″] Stocks continued to move higher, led by the Biotech’s, which were…
Read more[widget id=”text-22″] Twitter and AMD Options Stand Out, Is There A Double Top In Biotech? The stock market overall had another dull day, with the S&P 500 down less than…
Read more[widget id=”text-23″] Roku’s Borrow Rate Rises, plus Biogen, Acadia, Tesla, and Nvidia [widget id=”text-19″] The sell-off continued again with the S&P 500 trading down to roughly 2,646, where a sturdy…
Read more[widget id=”text-23″] Micron’s Massive Breakout, Plus Skyworks, Lam, Biogen, Alnylam & More The stock market was mixed on Monday, with the S&P 500 finishing the day down slightly. Technology and…
Read more[widget id=”text-23″] Biotech and Tech Stocks Are Approaching Make Or Break Moments The stock market picked right up from where it left off last week, with the S&P 500 continuing…
Read more[widget id=”text-22″] Acadia, Biogen, Celgene, Regeneron In Focus – A Look At The Week Ahead The stock market will look to build on last weeks gains, and it will be…
Read more[widget id=”wordads_sidebar_widget-41″] Biotech Stocks Continue To Soar, More Gains To Come [widget id=”text-16″] Biotech stocks continue to soar, and Biogen and Gilead had big days on Friday. Biogen jumped by nearly…
Read more[widget id=”wordads_sidebar_widget-41″] Why Biotech Stocks Will Continue To Reach Record Heights [widget id=”text-16″] Biotech stocks continue to rip higher, with the S&P Biotech ETF ($XBI) reaching a new record high,…
Read moreWhat The Market Thinks About Biogen’s Upcoming Results In this premium video, we take a look at what the market may be expecting when Biogen reports results on January 25.…
Read more[widget id=”wordads_sidebar_widget-41″] Under Armour, Bitcoin, AMD, Biogen, Gilead, Pfizer – Monster Commentary [widget id=”text-16″] S&P 500 The S&P 500 had a relatively uneventful day, with the index finishing the day…
Read more[widget id=”text-15″] [widget id=”wordads_sidebar_widget-41″] Stock Market Sells Off As Biotech Gets Rocked, Again! Just more of the same isn’t? Gap up at the open, then a slow drag lower the…
Read more[widget id=”wordads_sidebar_widget-18″] Bitcoin, AMD, Nvidia, Biotech, Could Apple iPhone Worries Be Overblown It is a new year, and with that everything gets reset back to zero, but other than not…
Read moreTesla and Biotech’s Have Soared, While Chips and Tech Still Struggle The past couple of trading sessions have seen shares of Tesla rise from roughly $310 to $340, while biotechs…
Read moreThe Monster Week Ahead: Watching – The VIX, Nvidia, Micron, Tesla & Biotech We could see a much more relaxed market than the one we saw last week. With Tax…
Read more